TrialUrology2021

Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non-muscle-invasive Bladder Cancer.

Harry Herr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.